|
Vertex Pharmaceuticals Has Returned 20.5% Since SmarTrend Recommendation (VRTX)
Feb 14, 2012 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend identified an Uptrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on December 14th, 2011 at $29.99. In approximately 2 months, Vertex Pharmaceuticals has returned 20.49% as of today's recent price of $36.13.
Over the past year, Vertex Pharmaceuticals has traded in a range of $26.50 to $58.87 and is now at $36.13, 36% above that low. The 200-day and 50-day moving averages have moved 0.55% lower and 1.53% higher over the past week, respectively.
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Vertex Pharmaceuticals shares.Log in and add Vertex Pharmaceuticals (VRTX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Write to Chip Brian at cbrian@mysmartrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
[ Back To TMCnet.com's Homepage ]
|
TMCnet LOGIN
Webinars
